These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12697169)

  • 1. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
    McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
    Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
    McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
    Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
    Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
    Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
    Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
    ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
    McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
    Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first two cantharidin analogues displaying PP1 selectivity.
    McCluskey A; Keane MA; Walkom CC; Bowyer MC; Sim AT; Young DJ; Sakoff JA
    Bioorg Med Chem Lett; 2002 Feb; 12(3):391-3. PubMed ID: 11814804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
    Baba Y; Hirukawa N; Tanohira N; Sodeoka M
    J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
    McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
    Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
    Stewart SG; Hill TA; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem; 2007 Dec; 15(23):7301-10. PubMed ID: 17870547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor imide derivatives of 7-oxabicyclo[2.2.1]heptane-2,3-dimethyl-2,3-dicarboxylic acid.
    Walter WG
    J Pharm Sci; 1989 Jan; 78(1):66-7. PubMed ID: 2709322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?
    McCuskey A; Keane MA; Mudgee LM; Sim AT; Sakoff J; Quinn RJ
    Eur J Med Chem; 2000 Oct; 35(10):957-64. PubMed ID: 11121622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
    Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
    ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
    Li YM; Mackintosh C; Casida JE
    Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
    Yeh CB; Su CJ; Hwang JM; Chou MC
    Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Cantharidin and its Analogues.
    Wang G; Dong J; Deng L
    Curr Med Chem; 2018; 25(17):2034-2044. PubMed ID: 28413963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
    Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
    Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cantharidin and cantharidin derivates on tumour cells.
    Liu D; Chen Z
    Anticancer Agents Med Chem; 2009 May; 9(4):392-6. PubMed ID: 19442040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.